By staff writers

March 20, 2013 -- Diagnostic agent developer Lantheus Medical Imaging has inked a five-year molybdenum-99 (Mo-99) supply contract with the Institute for Radioelements (IRE).

Lantheus will use the IRE-supplied Mo-99 in its TechneLite technetium-99 (Tc-99m) generators. The agreement, which runs through December 31, 2017, is designed to make Lantheus less vulnerable to supply shortages, according to the vendor.

The agreement also provides for the transition to Mo-99 sourced from low-enriched uranium (LEU) targets once IRE completes its ongoing conversion program to modify its facilities and processes in accordance with Belgian nuclear security commitments, Lantheus said.

Copyright © 2013

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking